This new 1,157-page report from the author contains 65 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including:
- Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- An extensive review of DNA probe and biochip Technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
- Five-year test volume and reagent sales forecasts.
- Review of testing methodologies an instrumentation Technologies.
- Feature comparison of automated and semi automated analyzers.
- Sales and market shares of leading suppliers.
- Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
- Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
Companies Mentioned
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- Decode Genetics
- Diadexus
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic
- Illumina
- LabCorp
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- PerkinElmer
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
